Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113762.1.4.1235.154 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.154 |
version | 20221012 |
status | active |
publisher | B.well Connected Health Steward |
name | Dyslipidemia_ICD10 |
title | Dyslipidemia_ICD10 |
date | 2022-10-12T01:13:05-04:00 |
experimental | false |
description | b.well created value set by Sr. Clinical Business Analyst for Dyslipidemia Condition. |
Usages |
|
This value set contains 10 concepts
Code | System | Display |
E78.00 | http://hl7.org/fhir/sid/icd-10-cm | Pure hypercholesterolemia, unspecified |
E78.01 | http://hl7.org/fhir/sid/icd-10-cm | Familial hypercholesterolemia |
E78.1 | http://hl7.org/fhir/sid/icd-10-cm | Pure hyperglyceridemia |
E78.2 | http://hl7.org/fhir/sid/icd-10-cm | Mixed hyperlipidemia |
E78.4 | http://hl7.org/fhir/sid/icd-10-cm | Other hyperlipidemia |
E78.41 | http://hl7.org/fhir/sid/icd-10-cm | Elevated Lipoprotein(a) |
E78.49 | http://hl7.org/fhir/sid/icd-10-cm | Other hyperlipidemia |
E78.5 | http://hl7.org/fhir/sid/icd-10-cm | Hyperlipidemia, unspecified |
E78.6 | http://hl7.org/fhir/sid/icd-10-cm | Lipoprotein deficiency |
T46.6X5A | http://hl7.org/fhir/sid/icd-10-cm | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
Produced 08 Sep 2023